Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More..

Wall Street Journal

Benzinga

IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC

India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”

Benzinga

Food industry wary of mandates ahead of hunger conference - Roll Call

As the administration prepares for its Sept. 28 hunger conference, the food industry is wary of new labeling mandates.

Roll Call

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA seems poised to approve a new drug for ALS, but does it work?

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

WEKU

FDA warns cooks about "NyQuil Chicken"

TikTok users are apparently bringing to cold and flu medicine into the kitchen, with potentially poisonous results

Salon

Don’t cook your chicken in Nyquil, FDA warns after viral social media trend resurfaces

“These video challenges, which often target youths, can harm people — and even cause death,” the agency said.

The Independent UK

FDA concedes delays in response to baby formula shortage

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

FDA Says No Way To Food Companies Wanting To Get On The CBD Gravy Train

As several major food makers are champing at the bit to cash in on the CBD food and drinks craze, it seems the FDA is still not down with the program.

Benzinga

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

StockNews.com

Dow Dips 400 Points; Ford Shares Slide

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.

Benzinga

Nasdaq Down 50 Points; Crude Oil Falls Sharply

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.

Benzinga

Family Dollar recalls Colgate products that were improperly stored

Family Dollar says it is not aware of any complaints from customers nor any reports of illnesses related to the recall.

WEKU

PSI suspended for allegedly promising govt. job in return for bribe

MYSURU

The Hindu

Bluebird’s gene therapy for brain disease receives accelerated approval

Bluebird Bio Inc.’s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment of its kind for children living with cerebral adrenoleukodystrophy.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

The Hindu

Congress releases audio of alleged scam in FDA recruitment

MYSURU

Benzinga

FDA Okays bluebird bio's $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know

Biotechnology company, bluebird bio, Inc. (NASDAQ: BLUE) announced late Friday that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.

The Hindu

Maharashtra FDA cancels Johnson & Johnson's baby powder manufacturing licence

The State government agency said the company's product, Johnson's Baby Powder, may affect the skin of newborn babies

StockNews.com

1 Stock That’ll Make You Turn Blue in the Face for Owning

Biotech company bluebird bio (BLUE) received FDA approval for ZYNTEGLO last month, which seems to have boosted its stock price. However, given its bleak profitability and stretched valuations, the stock might be best avoided. Read on….

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

California and New York aim to curb diet pill sales to minors

California and New York are on the cusp of going further than the FDA in restricting the sale of non-prescription diet pills to minors as pediatricians and public health advocates try to protect kids from extreme weight-loss gimmicks online.

Benzinga

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy individuals 10 through 25 years of age. The trial met all primary and secondary endpoints. Pfizer shares traded in a range of $45.7…

Daily Record

Experts debunk bizarre celebrity health trends from 'Vampire Facial' to drinking wee

Health professionals hit out at some of the wacky ways stars to stay in top shape - such as Kim Kardashian's face smeared and injected with her own blood.

Benzinga

Bipartisan Lawmakers Call Out FDA's 'Inadequate' Response To Hemp And CBD Regulations

Bipartisan House members sent a letter to the FDA commissioner to complain about the agency's “completely insufficient response” to their bill, which called for hemp-derived CBD to be permitted and regulated as a food additive.

The Independent UK

US warns monkeypox could mutate to resist antiviral drug

U.S. health officials are warning doctors against overusing the lone drug available to treat monkeypox

Investors Business Daily

Something Unusual Is Happening Right Now With Biotech Stocks

Biotech stocks have swung sharply higher, buoyed by several factors. Could they be poised to lead the market though the next big upturn?

Daily Mirror

Outrageous celebrity health trends debunked - from Kim K's 'Vampire Facial' to vaginal sunbathing

Some of the more wild and wacky methods our stars use to stay in tip-top shape are not really such a great idea, warn experts

1 … 110 111 112 113

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party